YTEN Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $0.24 and $17.26. With a market capitalization of about $345.46 thousand, Yield10 Bioscience, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.43). Key stats such as the average daily volume over the past year has been around 5.09 thousand shares, trading with heavier-than-usual volume. Headquartered in Woburn, MA, Yield10 Bioscience, Inc. operates in the Basic Materials sector and the Agricultural Inputs industry. Led by CEO Oliver P. Peoples, the company employs approximately 29 people and listed since November 10, 2006. Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada.

Short-term trend indicators are bullishly aligned (SMA20 -55.01%, SMA50 -63.9%, SMA200 -70.5%). The stock’s 14-day RSI is 27.6 (weak momentum), while the ATR of 1.2 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -96.81% below its high and over 18.5% above its low.

Yield10 Bioscience, Inc. trades at a P/E ratio of -0.01, slightly below the S&P 500 average, with a price-to-sales ratio of 5.76 and a price-to-book ratio of -0.04 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.03, also below market averages.

Yield10 Bioscience, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.29. This means the shares are trading below this model’s fair value.

Yield10 Bioscience, Inc. generated EPS of -$50.04 over the past year. Five-year average earnings growth is 45.25%. Wall Street analysts project EPS growth of 0.0% annually over the next five years. Yield10 Bioscience, Inc. earnings surprise history is a mixed track record. The quarter that ended August 14, 2024, missed forecasts by -99.87%. The prior quarter beat by -99.82%. Over the last six quarters, Apple has recorded several small beats. These include 33.33% in August 14, 2023.

Yield10 Bioscience, Inc. has 692.68 thousand shares outstanding. The public float is 537.50 thousand shares, elevated short interest at 0.45% of float. This equals 2.53 thousand shares. The short ratio is 0.03 days. Institutional investors hold 0.04% of the float. Insiders own 17.55%. SCULLY WILLIAM P holds 2.93 million shares, Peoples Oliver P has 67.63 thousand shares and SCHULER JACK W has 63.79 thousand shares.